We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
62 hedge funds and large institutions have $47M invested in Larimar Therapeutics in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
571% more call options, than puts
Call options by funds: $47K | Put options by funds: $7K
0% more capital invested
Capital invested by funds: $46.8M → $47M (+$194K)
0% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 17
0.01% less ownership
Funds ownership: 4.06% → 4.05% (-0.01%)
10% less funds holding
Funds holding: 69 → 62 (-7)
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
Holders
62
Holders Change
-7
Holders Change %
-10.14%
% of All Funds
1.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
17
Reduced
17
Closed
12
Calls
$47K
Puts
$7K
Net Calls
+$40K
Net Calls Change
+$133K
Top Buyers
| 1 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$1.94M |
| 2 |
AC
Armistice Capital
New York
|
+$1.32M |
| 3 |
Renaissance Technologies
New York
|
+$886K |
| 4 |
6CM
683 Capital Management
New York
|
+$352K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$234K |
Top Sellers
| 1 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$822K |
| 2 |
Goldman Sachs
New York
|
-$642K |
| 3 |
Millennium Management
New York
|
-$552K |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$510K |
| 5 |
ECM
Element Capital Management
New York
|
-$316K |
